Literature DB >> 18815124

Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks.

Masaaki Oyama1, Hiroko Kozuka-Hata, Shinya Tasaki, Kentaro Semba, Seisuke Hattori, Sumio Sugano, Jun-ichiro Inoue, Tadashi Yamamoto.   

Abstract

Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Because phosphotyrosine-dependent networks play a key role in transmitting signals, a comprehensive and fine description of their dynamic behavior can lead us to systematically analyze the regulatory mechanisms that result in each biological effect. Here we established a mass spectrometry-based framework for analyzing tyrosine phosphoproteome dynamics through temporal network perturbation. A highly time-resolved description of the epidermal growth factor-dependent signaling pathways in human A431 cells revealed a global view of their multiphase network activation, comprising a spike signal transmission within 1 min of ligand stimulation followed by the prolonged activation of multiple Src-related molecules. Temporal perturbation of Src family kinases with the corresponding inhibitor PP2 in the prolonged activation phase led to the down-regulation of the molecules related to cell adhesion and receptor degradation, whereas the canonical cascades as well as the epidermal growth factor receptor relatively maintained their activities. Our methodology provides a system-wide view of the regulatory network clusters involved in signal transduction that is essential to refine the literature-based network structures for a systems biology analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815124     DOI: 10.1074/mcp.M800186-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  23 in total

1.  Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer.

Authors:  Masaaki Oyama; Takeshi Nagashima; Takashi Suzuki; Hiroko Kozuka-Hata; Noriko Yumoto; Yuichi Shiraishi; Kazuhiro Ikeda; Yoko Kuroki; Noriko Gotoh; Takanori Ishida; Satoshi Inoue; Hiroaki Kitano; Mariko Okada-Hatakeyama
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 2.  Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis.

Authors:  Renu Goel; H C Harsha; Akhilesh Pandey; T S Keshava Prasad
Journal:  Mol Biosyst       Date:  2011-12-08

Review 3.  Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.

Authors:  Chaochao Wu; Jicheng Duan; Tao Liu; Richard D Smith; Wei-Jun Qian
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-01-12       Impact factor: 3.205

4.  Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.

Authors:  Kian Kani; Vitor M Faca; Lindsey D Hughes; Wenxuan Zhang; Qiaojun Fang; Babak Shahbaba; Roland Luethy; Jonathan Erde; Joanna Schmidt; Sharon J Pitteri; Qing Zhang; Jonathan E Katz; Mitchell E Gross; Sylvia K Plevritis; Martin W McIntosh; Anjali Jain; Samir Hanash; David B Agus; Parag Mallick
Journal:  Mol Cancer Ther       Date:  2012-03-12       Impact factor: 6.261

5.  Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

Authors:  Guolin Zhang; Bin Fang; Richard Z Liu; Huiyi Lin; Fumi Kinose; Yun Bai; Umut Oguz; Elizabeth R Remily-Wood; Jiannong Li; Soner Altiok; Steven Eschrich; John Koomen; Eric B Haura
Journal:  J Proteome Res       Date:  2010-12-03       Impact factor: 4.466

Review 6.  Quantitative analysis of global phosphorylation changes with high-resolution tandem mass spectrometry and stable isotopic labeling.

Authors:  Hye Kyong Kweon; Philip C Andrews
Journal:  Methods       Date:  2013-04-21       Impact factor: 3.608

7.  Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.

Authors:  Shinya Tasaki; Masao Nagasaki; Hiroko Kozuka-Hata; Kentaro Semba; Noriko Gotoh; Seisuke Hattori; Jun-ichiro Inoue; Tadashi Yamamoto; Satoru Miyano; Sumio Sugano; Masaaki Oyama
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

8.  Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.

Authors:  Daisuke Tokuhara; Beatriz Álvarez; Mio Mejima; Tomoko Hiroiwa; Yuko Takahashi; Shiho Kurokawa; Masaharu Kuroda; Masaaki Oyama; Hiroko Kozuka-Hata; Tomonori Nochi; Hiroshi Sagara; Farah Aladin; Harold Marcotte; Leon G J Frenken; Miren Iturriza-Gómara; Hiroshi Kiyono; Lennart Hammarström; Yoshikazu Yuki
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

9.  Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.

Authors:  Koji Kashima; Yoshikazu Yuki; Mio Mejima; Shiho Kurokawa; Yuji Suzuki; Satomi Minakawa; Natsumi Takeyama; Yoshiko Fukuyama; Tatsuhiko Azegami; Takeshi Tanimoto; Masaharu Kuroda; Minoru Tamura; Yasuyuki Gomi; Hiroshi Kiyono
Journal:  Plant Cell Rep       Date:  2015-12-11       Impact factor: 4.570

10.  Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing.

Authors:  Ryutaro Fukui; Shin-ichiroh Saitoh; Fumi Matsumoto; Hiroko Kozuka-Hata; Masaaki Oyama; Koichi Tabeta; Bruce Beutler; Kensuke Miyake
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.